Occupe actuellement des postes chez Ardelyx Inc, Epizyme Inc, Mersana Therapeutics Inc and Adaptimmune Therapeutics PLC
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Ardelyx Inc | 1 mars 2014 - |
Independent Chairman of the Board | Epizyme Inc | 1 avril 2016 - |
Independent Chairman of the Board | Mersana Therapeutics Inc | 1 janvier 2017 - |
Non-Executive Independent Chairman of the Board | Adaptimmune Therapeutics PLC | 1 janvier 2017 - |
Independent Chairman of the Board | TESARO Inc | 1 juillet 2011 - 22 janvier 2019 |
Chairman of the Board | Mersana Therapeutics Inc | 1 novembre 2013 - 1 janvier 2017 |
Non-Executive Vice Chairman of the Board | Adaptimmune Therapeutics PLC | 24 mai 2016 - 1 janvier 2017 |
Non-Executive Independent Director | Adaptimmune Therapeutics PLC | 1 septembre 2014 - 24 mai 2016 |
Independent Director | Epizyme Inc | 1 décembre 2009 - 1 avril 2016 |
Director | Ardelyx Inc | 1 mars 2009 - 1 mars 2014 |
Chairman of the Board | Mersana Therapeutics Inc | 1 juillet 2012 - 1 novembre 2013 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2022-11-17 | 2022-11-17 |
Ardelyx Inc
(ARDX)
|
A Achat |
567 000
+94.5%
1,761 000 642 USD |
567 000 +94.5% | 1,76 | 1 000 642 USD | |
2022-02-23 | 2022-02-23 |
Imara Inc
(IMRA)
|
A Achat |
35 257
+18.2%
1,4651 475 USD |
35 257 +18.2% | 1,46 | 51 475 USD | |
2022-02-23 | 2022-02-22 |
Imara Inc
(IMRA)
|
A Achat |
65 817
+51.4%
1,56102 675 USD |
65 817 +51.4% | 1,56 | 102 675 USD | |
2022-02-23 | 2022-02-18 |
Imara Inc
(IMRA)
|
A Achat |
50 398
+64.8%
1,3065 517 USD |
50 398 +64.8% | 1,30 | 65 517 USD | |
2022-02-17 | 2022-02-17 |
Imara Inc
(IMRA)
|
A Achat |
14 595
+23.1%
1,1717 076 USD |
14 595 +23.1% | 1,17 | 17 076 USD | |
2022-02-17 | 2022-02-16 |
Imara Inc
(IMRA)
|
A Achat |
11 779
+22.9%
1,2014 135 USD |
11 779 +22.9% | 1,20 | 14 135 USD | |
2022-02-17 | 2022-02-15 |
Imara Inc
(IMRA)
|
A Achat |
19 552
+61.4%
1,2023 462 USD |
19 552 +61.4% | 1,20 | 23 462 USD | |
2022-02-14 | 2022-02-14 |
Imara Inc
(IMRA)
|
A Achat |
8 500
+36.4%
1,1810 030 USD |
8 500 +36.4% | 1,18 | 10 030 USD | |
2022-02-14 | 2022-02-11 |
Imara Inc
(IMRA)
|
A Achat |
14 573
+166.5%
1,2317 925 USD |
14 573 +166.5% | 1,23 | 17 925 USD | |
2022-02-14 | 2022-02-10 |
Imara Inc
(IMRA)
|
A Achat |
8 753
+inf%
1,2911 291 USD |
8 753 +inf% | 1,29 | 11 291 USD | |
2021-03-29 | 2021-03-26 |
Epizyme Inc
(EPZM)
|
A Achat |
217
+0.1%
7,801 693 USD |
217 +0.1% | 7,80 | 1 693 USD | |
2021-03-29 | 2021-03-26 |
Epizyme Inc
(EPZM)
|
A Achat |
34 269
+29.4%
7,97273 124 USD |
34 269 +29.4% | 7,97 | 273 124 USD | |
2021-03-29 | 2021-03-25 |
Epizyme Inc
(EPZM)
|
A Achat |
28 231
+32.0%
7,98225 283 USD |
28 231 +32.0% | 7,98 | 225 283 USD | |
2020-12-10 | 2020-12-10 |
Ardelyx Inc
(ARDX)
|
A Achat |
170 000
+68.7%
5,891 000 841 USD |
170 000 +68.7% | 5,89 | 1 000 841 USD | |
2020-06-26 | 2020-06-26 |
Epizyme Inc
(EPZM)
|
A Achat |
62 019
+301.3%
16,03994 165 USD |
62 019 +301.3% | 16,03 | 994 165 USD | |
2020-06-26 | 2020-06-25 |
Ardelyx Inc
(ARDX)
|
A Achat |
68 373
+38.2%
6,96476 040 USD |
68 373 +38.2% | 6,96 | 476 040 USD | |
2020-06-26 | 2020-06-24 |
Ardelyx Inc
(ARDX)
|
A Achat |
72 598
+68.3%
6,75489 862 USD |
72 598 +68.3% | 6,75 | 489 862 USD | |
2020-06-24 | 2020-06-22 |
Ardelyx Inc
(ARDX)
|
A Achat |
4 673
+4.6%
6,7531 525 USD |
4 673 +4.6% | 6,75 | 31 525 USD | |
2020-04-09 | 2020-04-07 |
Mersana Therapeutics Inc
(MRSN)
|
A Achat |
538 599
+inf%
5,593 010 768 USD |
538 599 +inf% | 5,59 | 3 010 768 USD | |
2020-01-28 | 2020-01-24 |
Adaptimmune Therapeutics PLC
(ADAP)
|
A Achat |
7 500 000
+62.5%
0,675 000 250 USD |
7 500 000 +62.5% | 0,67 | 5 000 250 USD | |
2019-07-24 | 2019-07-22 |
Mirum Pharmaceuticals Inc
(MIRM)
|
A Achat |
450 000
+12.0%
15,006 750 000 USD |
450 000 +12.0% | 15,00 | 6 750 000 USD | |
2019-06-28 | 2019-06-27 |
Epizyme Inc
(EPZM)
|
V Vente |
52 473
-100.0%
12,43652 134 USD |
52 473 -100.0% | 12,43 | 652 134 USD | |
2019-06-26 | 2019-06-26 |
Epizyme Inc
(EPZM)
|
V Vente |
52 472
-50.0%
12,85674 176 USD |
52 472 -50.0% | 12,85 | 674 176 USD | |
2019-06-26 | 2019-06-25 |
Epizyme Inc
(EPZM)
|
V Vente |
52 472
-33.3%
13,31698 649 USD |
52 472 -33.3% | 13,31 | 698 649 USD | |
2019-06-25 | 2019-06-24 |
Genocea Biosciences Inc
(GNCA)
|
A Achat |
2 857 142
+65.4%
3,509 999 997 USD |
2 857 142 +65.4% | 3,50 | 9 999 997 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
1 500 000
+51.0%
10,0015 000 000 USD |
1 500 000 +51.0% | 10,00 | 15 000 000 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
1 000 000
+51.6%
10,0010 000 000 USD |
1 000 000 +51.6% | 10,00 | 10 000 000 USD | |
2019-05-09 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
1 136 704
+124.1%
1,081 227 640 USD |
1 136 704 +124.1% | 1,08 | 1 227 640 USD | |
2019-04-08 | 2019-04-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
4 347 827
+20.8%
1,144 956 523 USD |
4 347 827 +20.8% | 1,14 | 4 956 523 USD | |
2019-03-06 | 2019-03-05 |
Mersana Therapeutics Inc
(MRSN)
|
A Achat |
3 750 000
+46.1%
4,0015 000 000 USD |
3 750 000 +46.1% | 4,00 | 15 000 000 USD | |
2019-02-19 | 2019-02-14 |
Genocea Biosciences Inc
(GNCA)
|
A Achat |
9 948 269
+39.8%
0,474 688 619 USD |
9 948 269 +39.8% | 0,47 | 4 688 619 USD | |
2018-12-21 | 2018-12-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
300 000
+1.5%
1,49448 380 USD |
300 000 +1.5% | 1,49 | 448 380 USD | |
2018-12-21 | 2018-12-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
200 000
+1.0%
1,63326 060 USD |
200 000 +1.0% | 1,63 | 326 060 USD | |
2018-12-12 | 2018-12-11 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
61 200
+0.3%
1,98121 084 USD |
61 200 +0.3% | 1,98 | 121 084 USD | |
2018-12-10 | 2018-12-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
26 000
+0.1%
1,9851 576 USD |
26 000 +0.1% | 1,98 | 51 576 USD | |
2018-12-10 | 2018-12-07 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
117 100
+0.6%
1,98232 362 USD |
117 100 +0.6% | 1,98 | 232 362 USD | |
2018-12-10 | 2018-12-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
27 300
+0.1%
1,9954 414 USD |
27 300 +0.1% | 1,99 | 54 414 USD | |
2018-11-30 | 2018-11-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
71 900
+0.4%
1,98142 067 USD |
71 900 +0.4% | 1,98 | 142 067 USD | |
2018-11-30 | 2018-11-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
24 500
+0.1%
1,9948 824 USD |
24 500 +0.1% | 1,99 | 48 824 USD | |
2018-11-21 | 2018-11-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
170 000
+0.9%
1,98336 107 USD |
170 000 +0.9% | 1,98 | 336 107 USD | |
2018-11-19 | 2018-11-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
510 000
+2.6%
1,88956 658 USD |
510 000 +2.6% | 1,88 | 956 658 USD | |
2018-11-19 | 2018-11-16 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
350 000
+1.8%
1,86649 355 USD |
350 000 +1.8% | 1,86 | 649 355 USD | |
2018-11-19 | 2018-11-15 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
340 000
+1.8%
1,86631 958 USD |
340 000 +1.8% | 1,86 | 631 958 USD | |
2018-08-22 | 2018-08-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
663 716
+3.7%
2,261 499 998 USD |
663 716 +3.7% | 2,26 | 1 499 998 USD | |
2018-07-20 | 2018-07-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
50 600
+0.3%
2,00101 165 USD |
50 600 +0.3% | 2,00 | 101 165 USD | |
2018-07-20 | 2018-07-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
200 000
+1.1%
1,95390 580 USD |
200 000 +1.1% | 1,95 | 390 580 USD | |
2018-06-28 | 2018-06-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
187 130
+1.1%
2,10392 692 USD |
187 130 +1.1% | 2,10 | 392 692 USD | |
2018-06-28 | 2018-06-27 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
5 295
+0.0%
2,1511 384 USD |
5 295 +0.0% | 2,15 | 11 384 USD | |
2018-05-30 | 2018-05-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
275
+0.0%
2,15591 USD |
275 +0.0% | 2,15 | 591 USD | |
2018-05-21 | 2018-05-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
32 200
+0.2%
2,1469 059 USD |
32 200 +0.2% | 2,14 | 69 059 USD | |
2018-05-21 | 2018-05-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
20 100
+0.1%
2,1442 928 USD |
20 100 +0.1% | 2,14 | 42 928 USD | |
2018-05-21 | 2018-05-17 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
184 179
+1.1%
2,13391 436 USD |
184 179 +1.1% | 2,13 | 391 436 USD | |
2018-05-10 | 2018-05-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
70 873
+0.4%
2,13151 250 USD |
70 873 +0.4% | 2,13 | 151 250 USD | |
2018-04-10 | 2018-04-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
203 200
+1.2%
2,46499 994 USD |
203 200 +1.2% | 2,46 | 499 994 USD | |
2018-04-10 | 2018-04-09 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
32 100
+0.2%
2,4378 099 USD |
32 100 +0.2% | 2,43 | 78 099 USD | |
2018-04-10 | 2018-04-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
685 676
+4.2%
2,241 536 943 USD |
685 676 +4.2% | 2,24 | 1 536 943 USD | |
2017-03-29 | 2017-03-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
6 000 000
+57.9%
0,503 000 000 USD |
6 000 000 +57.9% | 0,50 | 3 000 000 USD |